Keren David-Zarbiv
Chief Tech/Sci/R&D Officer chez MEDIWOUND LTD.
Provenance du réseau au premier degré de Keren David-Zarbiv
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 35 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Keren David-Zarbiv via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | General Counsel Corporate Officer/Principal Corporate Officer/Principal Director/Board Member | |
| DERMA SCIENCES INC | Medical Specialties | Chief Executive Officer Public Communications Contact | |
| GIVEN IMAGING LTD. | Electronic Equipment/Instruments | Chief Executive Officer Corporate Officer/Principal | |
| STRATA SKIN SCIENCES, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
OPKO Biologics Ltd.
 OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
eXIthera Pharmaceuticals, Inc.
 eXIthera Pharmaceuticals, Inc. BiotechnologyHealth Technology eXIthera Pharmaceuticals, Inc. develops and manufactures stroke prevention and antithrombosis drugs. Its drugs are based on the pathophysiological role of Factor XI in the initiation of intravascular thrombi without causing undue bleeding. The firm’s drug candidates are small, orally active, and highly selective Factor XI inhibitors. The company was founded by Neil J. Hayward and Frans L. Stassen in 2012 and is headquartered in Westborough, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Undergraduate Degree | |
| SCIGEN LIMITED | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
Quark Pharmaceuticals, Inc.
 Quark Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quark Pharmaceuticals, Inc. discovers and develops novel RNAi-based therapeutics. The firm’s products include QPI-1002 and QPI-1007 is being developed as a neuroprotective agent for the treatment of optic neuropathies that result in the death of retinal ganglion cells. The company was founded by Daniel Zurr, David M. Fineman and J. Gregory Swendsen in December 1993 and is headquartered in Fremont, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Executive Officer Director/Board Member Corporate Secretary Director/Board Member Chief Executive Officer | |
| SOL-GEL TECHNOLOGIES LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree Doctorate Degree Masters Business Admin Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Doctorate Degree | |
| UNIVO PHARMACEUTICALS LTD | Biotechnology | Chairman Director/Board Member General Counsel Director/Board Member Director/Board Member | |
| Technion-Israel Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Graduate Degree Undergraduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
ColBar LifeScience Ltd.
 ColBar LifeScience Ltd. Medical SpecialtiesHealth Technology ColBar LifeSciences Ltd. develops technology for tissue regeneration and tissue engineering. It manufactures and commercializes bio surgical products for applications in reconstructive medicine and tissue engineering. Its main focus is on the repair of damaged tissue in the human body like soft tissue, bone and skin. The company was founded in 1995 and is headquartered in Herzliya, Israel. | Medical Specialties | President Director/Board Member | |
| Ben-Gurion University of the Negev | College/University | Corporate Officer/Principal Doctorate Degree Masters Business Admin Masters Business Admin Doctorate Degree | |
| Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree | |
| KAMADA LTD. | Biotechnology | Director/Board Member Director/Board Member | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Director/Board Member | |
| PROTALIX BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
| GAMIDA CELL LTD. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer Chairman Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree | |
Polyheal Ltd.
 Polyheal Ltd. Pharmaceuticals: MajorHealth Technology Polyheal Ltd. provides wound healing products. The company was founded by Vladimir Ritter and Dov Reichman in 1996 and is headquartered in Yavne, Israel. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Israel Bar Association
 Israel Bar Association Miscellaneous Commercial ServicesCommercial Services Israel Bar Association is a private company headquartered in Tel Aviv, Israel. The firm provides legal services. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
CureTech Ltd.
 CureTech Ltd. BiotechnologyHealth Technology CureTech Ltd. operates as a biotechnology company. It develops novel and immune modulating products for the treatment and control of cancer. The company was founded by Michael Schickler in 1995 and is headquartered in Yavne, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
Biokine Therapeutics Ltd.
 Biokine Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Biokine Therapeutics Ltd. Is a clinical-stage biopharmaceutical company, which engages in the research and development of biotechnologies for the treatment of cancer. It conducts a pre-clinical and clinical drug research that targets the tumor microenvironment of cancer cells. The company was founded by Amnon Peled in 2000 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Clal Life Sciences (CLS) LP
 Clal Life Sciences (CLS) LP Investment ManagersFinance Part of Clal Biotechnology Industries Ltd., Clal Life Sciences (CLS) LP is a venture capital fund. | Investment Managers | Director/Board Member Director/Board Member | |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Biotechnology | Director/Board Member Director/Board Member | |
| EXALENZ BIOSCIENCE LTD | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Investment Managers | Chief Executive Officer Chief Executive Officer Private Equity Investor | |
| SILVER CASTLE HOLDINGS LTD | Biotechnology | Director/Board Member | |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Haifa | College/University | Graduate Degree Undergraduate Degree | |
| Israeli Burn Association | Corporate Officer/Principal | ||
| CLAL Application Center Ltd. | Chairman Director/Board Member | ||
Pam-Bio Ltd.
 Pam-Bio Ltd. Pharmaceuticals: MajorHealth Technology Pam-Bio Ltd. develops drug therapy for acute bleeding conditions. The company was founded by Abd Al-Roof Higazi and Nuha Higazi on April 27, 2014 and is headquartered in Nazareth, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Ayana Pharma Ltd.
 Ayana Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ayana Pharma Ltd. is an Israeli pharmaceutical company that specializes in developing liposomal therapeutics for cancer treatment. The company is based in Jerusalem, Israel. Ayana Pharma was founded in 2012 by Yechezkel Barenholz and Avraham Molcho, with Yechezkel Barenholz serving as the CEO since its inception. | Pharmaceuticals: Major | Chairman | |
Wavelength Pharmaceuticals Ltd.
 Wavelength Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Wavelength Pharmaceuticals Ltd. develops and markets active pharmaceutical ingredients. The firm specializes in manufacturing cytotoxic, steroid and high potency and core competency in complex chemistries. It develops generic APIs and finished dose forms for a blue-chip customer base. The company is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
MediWound Germany GmbH
 MediWound Germany GmbH Medical DistributorsDistribution Services Part of MediWound Ltd., MediWound Germany GmbH is a company that wholesales medical devices and pharmaceutical products. The company is based in Ruesselsheim, Germany. The CEOs are Boaz Gur Lavie, Carsten Henke, Ety Klinger, Sharon Malka. The private company was founded in 2016. | Medical Distributors | Chief Executive Officer Chief Executive Officer | |
| Marstrands Dyk & Skeppshandel AB | Chairman | ||
| CACTUS ACQUISITION CORP. 1 LIMITED | Financial Conglomerates | Director of Finance/CFO Chairman Chief Executive Officer | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Valin Technologies Ltd. | Founder Chief Executive Officer | ||
| ELICIO THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistiques
Internationale
| Israël | 34 |
| Etats-Unis | 14 |
| Suède | 3 |
| Singapour | 2 |
| Allemagne | 2 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 9 |
| Finance | 5 |
| Electronic Technology | 2 |
| Commercial Services | 2 |
Opérationnelle
| Director/Board Member | 158 |
| Corporate Officer/Principal | 67 |
| Independent Dir/Board Member | 37 |
| Chief Executive Officer | 35 |
| Chairman | 29 |
Relations les plus connectées
| Insiders | |
|---|---|
| Ofer Gonen | 31 |
| Sarit Firon | 28 |
| Ruben Krupik | 23 |
| Stephen Wills | 22 |
| Assaf Segal | 19 |
| Samuel Rubinstein | 17 |
| Homi Shamir | 16 |
| Meron Mann | 15 |
| Roland Frösing | 14 |
| Avri Havron | 14 |
| Vickie R. Driver | 13 |
| Sharon Kochan | 13 |
| David Fox | 11 |
| Nissim Mashiach | 11 |
| Marian Gorecki | 10 |
- Bourse
- Insiders
- Keren David-Zarbiv
- Connexions Sociétés
